AG
LFCR icon

Algert Global’s Lifecore Biomedical LFCR Stock Holding History

Algert Global’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,206
Closed -$79K – 1234
2022
Q4 		$79K Hold
12,206
– – ﹤0.01% 1086
2022
Q3 		$109K Sell
12,206
-600
-5% -$6.1K 0.01% 1101
2022
Q2 		$128K Buy
12,806
+2,600
+25% +$25.7K 0.01% 1083
2022
Q1 		$118K Sell
10,206
-5,350
-34% -$59.6K 0.01% 1096
2021
Q4 		$173K Sell
15,556
-15,963
-51% -$155K 0.02% 874
2021
Q3 		$291K Buy
+31,519
New +$343K 0.04% 770
2020
Q2 		– Sell
-25,569
Closed -$222K – 463
2020
Q1 		$222K Sell
25,569
-1,140
-4% -$11.9K 0.09% 288
2019
Q4 		$302K Sell
26,709
-19,862
-43% -$211K 0.09% 262
2019
Q3 		$506K Sell
46,571
-740
-2% -$8.06K 0.19% 152
2019
Q2 		$443K Buy
47,311
+19,139
+68% +$193K 0.16% 182
2019
Q1 		$346K Sell
28,172
-42,457
-60% -$518K 0.2% 169
2018
Q4 		$836K Sell
70,629
-107,839
-60% -$1.48M 0.23% 149
2018
Q3 		$2.57M Buy
178,468
+4,088
+2% +$56.5K 0.55% 52
2018
Q2 		$2.6M Buy
174,380
+80,851
+86% +$1.12M 0.54% 64
2018
Q1 		$1.22M Buy
93,529
+68,617
+275% +$902K 0.24% 158
2017
Q4 		$314K Sell
24,912
-112,967
-82% -$1.43M 0.07% 253
2017
Q3 		$1.79M Buy
137,879
+2,394
+2% +$31.6K 0.41% 115
2017
Q2 		$2.01M Buy
+135,485
New +$1.89M 0.56% 68
2015
Q4 		– Sell
-56,297
Closed -$657K – 351
2015
Q3 		$657K Buy
56,297
+9,520
+20% +$126K 0.36% 97
2015
Q2 		$675K Buy
+46,777
New +$675K 0.37% 98
2013
Q4 		– Sell
-10,769
Closed -$131K – 363
2013
Q3 		$131K Sell
10,769
-3,590
-25% -$50.1K 0.04% 325
2013
Q2 		$190K Buy
+14,359
New +$199K 0.06% 249

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Algert Global's LFCR Position: Q1 2023 in Review

Algert Global sold out of Lifecore Biomedical (LFCR) in Q1 2023, closing a stake of 12,206 shares — an estimated $79K sold.

Algert Global first reported a position in LFCR in Q2 2013 and held it in 22 quarters. The position peaked at $2.6M in Q2 2018. 82 funds tracked by Wall St. Rank hold LFCR as of Q1 2023.

  • Algert Global reported no remaining Lifecore Biomedical position as of Q1 2023 after selling out during the quarter.
  • Algert Global sold 12,206 Lifecore Biomedical shares in Q1 2023, an estimated $79K.
  • Algert Global first reported a position in Lifecore Biomedical in Q2 2013 and held it in 22 quarters.
  • Algert Global's Lifecore Biomedical position peaked at $2.6M in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2023.

Based on Algert Global's 13F filing for Q1 2023, filed 12 May 2023.